
Healthpeak's AFFO Climbs 8% Amid Lab Impairments
Healthpeak Properties, Inc.Description
What this story covers
Healthpeak Properties' Q3 10-Q shows 5% revenue growth to $2.1B year-to-date, driven by merger synergies and CCRC strength, offset by $176M lab impairments. AFFO up 8% supports dividends, with robust liquidity and fixed-rate debt ensuring stability in challenging biotech markets.
Story snapshot
CompanyHealthpeak Properties, Inc.
TickerDOC
VariantStandard detailed
Duration14:24
Filing type10-Q
PeriodQ3 2025
IndustryReal Estate & Construction
Accession0001628280-25-046273
Full Story Script
Content not available for this story.